Close
Search for:
Search Button
Skip to primary navigation
Skip to main content
Skip to footer
Be Biopharma
Advancing our science with bold humanity
Investors & Media
News Releases
Publications & Presentations
Careers
Contact Us
Search
Our Company
Life at Be Bio
Our Science
Our Platform
Publications & Presentations
Patients & Caregivers
Home
/
In the News
/
Arch leads $130M round for cell therapy startup targeting cancer, rare disease
Arch leads $130M round for cell therapy startup targeting cancer, rare disease
Our Company
Life at Be Bio
Our Science
Our Platform
Publications & Presentations
Patients & Caregivers
Investors & Media
News Releases
Publications & Presentations
Careers
Contact Us
